Skip to main content
SpringerLink
Log in

Harninkontinenz

  • Chapter
  • First Online:
Neurogeriatrie

Zusammenfassung

Ein unfreiwilliger Urinverlust (Inkontinenz) gehört zu den häufigsten und besonders belastenden Folgen einer neurologischen Erkrankung im Alter. Die Inkontinenz führt zu sozialem Rückzug, Folgeerkrankungen, depressivem Verhalten und kann den Anlass für eine Heimunterbringung darstellen. Häufig stehen zunächst andere Funktionsdefizite im Vordergrund – die Basisdiagnostik einer neurogenen Harninkontinenz sollte jedoch in jeweils neurologische, geriatrische oder urologische Behandlungen eingebettet sein. Die Therapie umfasst neben verhaltenstherapeutischen auch medikamentöse und operative Interventionen und die Kombination von allen genannten. Das Behandlungskonzept sollte nach den Empfehlung der ICI ‚theory based‘, individuell, multi-komponent, multidisziplinär und Patienten-zentriert sein, also berufsgruppenübergreifend und interdisziplinär festgelegt werden und den neurologische Befund, die Ressourcen und Wünsche des Patienten sowie seiner Betreuungspersonen einbeziehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Abrams P (2003) Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urol 62:28–37

    Article  PubMed  Google Scholar 

  • Abrams P, Blaivas JG, Stanton SL, Andersen JT (1988) The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl 114:5–19

    CAS  PubMed  Google Scholar 

  • Abrams P, Kelleher C, Staskin D, Kay R, Martan A, Mincik I, Newgreen D, Ridder A, Paireddy A, van Maanen R (2017) Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY). World J Urol 35:827–838

    Google Scholar 

  • Ahluwalia RS, Johal N, Kouriefs C, Kooiman G, Montgomery BS, Plail RO (2006) The surgical risk of suprapubic catheter insertion and long-term sequelae. Ann R Coll Surg Engl 88:210–213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Amend B, Hennenlotter J, Schafer T, Horstmann M, Stenzl A, Sievert KD (2008) Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur Urol 53:1021–1028

    Article  CAS  PubMed  Google Scholar 

  • Ammirati E, Manassero A, Giammo A, Carone R (2017) Management of male and female neurogenic stress urinary incontinence in spinal cord injured (SCI) patients using adjustable continence therapy. Urologia 84:165–168

    Article  PubMed  Google Scholar 

  • Ammirati E, Manassero A, Giammò A, Carone R (2018) Male neurogenic stress urinary incontinence treated by artificial urinary sphincter AMS 800 (Boston Scientific, Boston, USA): very long-term results (>25 years). Prog Urol 28(1):39–47

    Google Scholar 

  • Anderson RU, Orenberg EK, Glowe P (2014) OnabotulinumtoxinA office treatment for neurogenic bladder incontinence in Parkinson’s disease. Urol 83:22–27

    Article  PubMed  Google Scholar 

  • Anding R, Kirschner-Hermanns R, Rantell A (2016) Wiedemann A [How Does Lower Urinary Tract Dysfunction Affekt Female Sexuality?]. Aktuelle Urol 47:300–304

    Article  CAS  PubMed  Google Scholar 

  • Anpalahan M, Gibson SJ (2008) Geriatric syndromes as predictors of adverse outcomes of hospitalization. Intern Med J 38:16–23

    Article  CAS  PubMed  Google Scholar 

  • Antunes AA, Srougi M, Coelho RF, de Campos FG (2007) Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Nat Clin Pract Urol 4:155–160

    Article  CAS  PubMed  Google Scholar 

  • Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23:322–330

    Article  PubMed  Google Scholar 

  • Bang RL (1994) Penile oedema induced by continuous condom catheter use and mimicking keloid scar. Scand J Urol Nephrol 28:333–335

    Article  CAS  PubMed  Google Scholar 

  • Bart S, De Seze M, Chartier-Kastler E (2007) Ruffion A [Lower urinary tract dysfunction and multiple sclerosis]. Prog Urol 17:358–364

    Article  CAS  PubMed  Google Scholar 

  • Baztan JJ, Arias E, Gonzalez N, Rodriguez de Prada MI (2005) New-onset urinary incontinence and rehabilitation outcomes in frail older patients. Age Ageing 34:172–175

    Article  PubMed  Google Scholar 

  • Brocklehurst JC (1993) Urinary incontinence in the community–analysis of a MORI poll. BMJ 306:832–834

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brown JS, Vittinghoff E, Wyman JF et al (2000) Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 48:721–725

    Article  CAS  PubMed  Google Scholar 

  • Browne C, Salmon N, Kehoe M (2015) Bladder dysfunction and quality of life for people with multiple sclerosis. Disabil Rehabil 37:2350–2358

    Article  PubMed  Google Scholar 

  • Callegari E1, Malhotra B, Bungay PJ, Webster R, Fenner KS, Kempshall S, LaPerle JL, Michel MC, Kay GG (2011) A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. Br J Clin Pharmacol 72:235–246

    Google Scholar 

  • Cameron AP, Clemens JQ, Latini JM, McGuire EJ (2009) Combination drug therapy improves compliance of the neurogenic bladder. J Urol 182:1062–1067

    Article  PubMed  Google Scholar 

  • Cevizci S, Uluocak S, Aslan C, Gokulu G, Bilir O, Bakar C (2015) Prevalence of falls and associated risk factors among aged population: community based cross-sectional study from Turkey. Cent Eur J Public Health 23:233–239

    Article  PubMed  Google Scholar 

  • Chancellor MB, Fowler CJ, Apostolidis A, de Groat WC, Smith CP, Somogyi GT, Aoki KR (2008) Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol 5:319–328

    Google Scholar 

  • Chancellor MB, Patel V, Leng WW, Shenot PJ, Lam W, Globe DR, Loeb AL, Chapple CR (2013) OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity. Neurol 81:841–848

    Google Scholar 

  • Chapple A, Prinjha S, Salisbury H (2014a) How users of indwelling urinary catheters talk about sex and sexuality: a qualitative study. Br J Gen Pract 64:e364–e371

    Article  PubMed  PubMed Central  Google Scholar 

  • Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC (2014b) Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn 33:17–30

    Article  CAS  PubMed  Google Scholar 

  • Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D (2008) The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 54:543–562

    Article  CAS  PubMed  Google Scholar 

  • Chen G, Liao L (2014) Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease. Spinal Cord https://doi.org/10.1038/sc.2014

  • Cheng T, Shuang WB Jia DD, Zhang M, Tont XN, Yang WD, Jia XM, Li S (2016) Efficacy and safety of OnabotulinumtoxinA in patients with neurogenic detrusor overactivity: a systematic review and meta-analysis of randomized controlled trials. PLoS One 11:e0159307

    Google Scholar 

  • Cohen BL, Barboglio P, Rodriguez D, Gousse AE (2009) Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units. Neurourol Urodyn 28:205–208

    Article  CAS  PubMed  Google Scholar 

  • Colling JC, Owen TR, McCreedy MR (1994) Urine volumes and voiding patterns among incontinent nursing home residents. Residents at highest risk for dehydration are often the most difficult to track. Geriatr Nurs 15:188–192

    Article  CAS  PubMed  Google Scholar 

  • Corrao G, Mazzola P, Monzio Compagnoni M, Rea F, Merlino L, Annoni G, Mancia G (2015) Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: a population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009. Drugs Aging 32:927–936

    Google Scholar 

  • Di Rezze S1, Frasca V, Inghilleri M, Durastanti V, Cortese A, Giacomelli E, Millefiorini E (2012) Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study. Clin Neuropharmacol 35:231–234

    Google Scholar 

  • Diefenbach K, Arold G, Wollny A, Schwantes U, Haselmann J, Roots I (2005) Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years. BJU Int 95:346–349

    Article  CAS  PubMed  Google Scholar 

  • Diefenbach K1, Donath F, Maurer A, Quispe Bravo S, Wernecke KD, Schwantes U, Haselmann J, Roots I (2003) Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteers. Clin Drug Investig 23:395–404

    Google Scholar 

  • Diokno AC, Brock BM, Herzog AR, Bromberg J (1990) Medical correlates of urinary incontinence in the elderly. Urol 36:129–138

    Article  CAS  PubMed  Google Scholar 

  • Dowson C, Watkins J, Khan MS, Dasgupta P, Sahai A (2012) Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates. Eur Urol 61:834–839

    Article  CAS  PubMed  Google Scholar 

  • Drake MJ, Apostolidis A, Cocci A, Emmanuel A, Gajewski JB, Harrison SC, Heesakkers JP, Lemack GE, Madersbacher H, Panicker JN, Radziszewski P, Sakakibara R, Wyndaele JJ (2016) Neurogenic lower urinary tract dysfunction: clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence 2013. Neurourol Urodyn 35:657–665

    Google Scholar 

  • Duchen LW (1972) Motor nerve growth induced by botulinum toxin as a regenerative phenomenon. Proc R Soc Med 65:196–197

    CAS  PubMed  PubMed Central  Google Scholar 

  • Dugan E, Cohen SJ, Bland DR, Preisser JS, Davis CC, Suggs PK, McGann P (2000) The association of depressive symptoms and urinary incontinence among older adults. J Am Geriatr Soc 48:413–416

    Google Scholar 

  • Elbadawi A, Diokno AC, Millard RJ (1998) The aging bladder: morphology and urodynamics. World J Urol 16(Suppl 1):S10–S34

    Article  PubMed  Google Scholar 

  • Elbadawi A, Yalla SV, Resnick NM (1993a) Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol 150:1668–1680

    Article  CAS  PubMed  Google Scholar 

  • Elbadawi A, Yalla SV, Resnick NM (1993b) Structural basis of geriatric voiding dysfunction. IV. Bladder outlet obstruction. J Urol 150:1681–1695

    Article  CAS  PubMed  Google Scholar 

  • Engeler DS, Meyer D, Abt D, Muller S, Schmid HP (2015) Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol 15:105

    Article  PubMed  PubMed Central  Google Scholar 

  • Ermengem E van (1979) Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as „Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus“ in Zeitschrift fur Hygiene und Infektionskrankheiten 26: 1–56, 1897. Rev Infect Dis 1:701–719

    Article  PubMed  Google Scholar 

  • Farag F, Koens M, Sievert KD, De Ridder D, Feitz W, Heesakkers J (2016) Surgical treatment of neurogenic stress urinary incontinence: a systematic review of quality assessment and surgical outcomes. Neurourol Urodyn 35:21–25

    Article  PubMed  Google Scholar 

  • Fowler CJ, Griffiths D, de Groat WC (2008) The neural control of micturition. Nat Rev Neurosci 9:453–466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fowler S, Godfrey H, Fader M, Timoney AG, Long A (2014) Living with a long-term, indwelling urinary catheter: catheter users’ experience. J Wound Ostomy Continence Nurs 41:597–603

    Article  PubMed  Google Scholar 

  • Fritel X, Lachal L, Cassou B, Fauconnier A, Dargent-Molina P (2013) Mobility impairment is associated with urge but not stress urinary incontinence in community-dwelling older women: results from the Ossebo study. BJOG 120:1566–1572

    Article  CAS  PubMed  Google Scholar 

  • Frohlich G, Burmeister S, Wiedemann A (1998) Bulitta M [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test]. Arzneimittelforschung 48:486–491

    CAS  PubMed  Google Scholar 

  • Gaspard L, Tombal B, Castille Y, Opsomer RJ (2014) Detrembleur C [Pelvic floor muscles training, electrical stimulation, bladder training and lifestyle interventions to manage lower urinary tract dysfunction in multiple sclerosis: a systematic review]. Prog Urol 24:222–228

    Article  CAS  PubMed  Google Scholar 

  • Gasquet I, Tcherny-Lessenot S, Gaudebout P, Bosio Le Goux B, Klein P, Haab F (2006) Influence of the severity of stress urinary incontinence on quality of life, health care seeking, and treatment: a national cross-sectional survey. Eur Urol 50:818–825

    Article  PubMed  Google Scholar 

  • George J, Tharion G, Richar J, Macaden AS, Thomas R, Bhattacharji S (2007) The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury. ScientificWorldJournal 7:1683–1690

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Giannantoni A, Di Stasi SM, Nardicchi V, Zucchi A, Macchioni L, Bini V, Goracci G, Porena M (2006) Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 175:2341–2344

    Google Scholar 

  • Hascoet J, Manunta A, Brochard C, Arnaud A, Damphousse M, Menard H, Kerdraon J, Journel H, Bonan I, Odent S, Fremond B, Siproudhis L, Gamé X, Peyronnet B (2017) Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: a systematic review. Neurourol Urodyn 36:557–564

    Google Scholar 

  • Haupt M, Thommes M, Heidenreich A, Breitkreutz J (2013) Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder. J Control Release 170:161–166

    Article  CAS  PubMed  Google Scholar 

  • Hellstrom L, Ekelund P, Milsom I, Mellstrom D (1990) The prevalence of urinary incontinence and use of incontinence aids in 85-year-old men and women. Age Ageing 19:383–389

    Article  CAS  PubMed  Google Scholar 

  • Hellstrom L, Ekelund P, Milsom I, Skoog I (1994) The influence of dementia on the prevalence of urinary and faecal incontinence in 85-year-old men and women. Arch Gerontol Geriatr 19:11–20

    Article  CAS  PubMed  Google Scholar 

  • Hennessey A, Robertson NP, Swingler R, Compston DA (1999) Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol 246:1027–1032

    Article  CAS  PubMed  Google Scholar 

  • Heudorf U, Gasteyer S, Muller M, Samoiski Y, Serra N, Westphal T (2016) Prevention and control of catheter-associated urinary tract infections - implementation of the recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) in nursing homes for the elderly in Frankfurt am Main, Germany. GMS Hyg Infect Control 11:Doc15

    Google Scholar 

  • Holroyd-Leduc JM, Mehta KM, Covinsky KE (2004) Urinary incontinence and its association with death, nursing home admission, and functional decline. J Am Geriatr Soc 52:712–718

    Article  PubMed  Google Scholar 

  • Hu TW, Wagner TH, Bentkover JD, LeBlanc K, Piancentini A, Stewart WF, Corey R, Zhou SZ, Hunt TL (2003) Estimated economic costs of overactive bladder in the United States. Urol 61:1123–1128

    Google Scholar 

  • Hu TW (1986) The economic impact of urinary incontinence. Clin Geriatr Med 2:673–687

    CAS  PubMed  Google Scholar 

  • Hui C, Keji X, Chonghe J, Ping T, Rubiao O, Jianweng Z, Xiangrong D, Liling Z, Maping H, Qingqing L, Qiuling L, Jiebing H, Tanghai H (2016) Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity. Spinal Cord 54:46–50

    Google Scholar 

  • Humblet M, Verpoorten C, Christiaens MH, Hirche H, Jansen K, Buyse G, van Gool JD (2015) Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters. Neurourol Urodyn 34:336–342

    Google Scholar 

  • Hunskaar S, Vinsnes A (1991) The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc 39:378–382

    Article  CAS  PubMed  Google Scholar 

  • Hunter KF, Moore KN, Allen M (2008) Lower urinary tract symptoms in older adults undergoing hip arthroplasty: a feasibility study. J Wound Ostomy Continence Nurs 35:334–340

    Article  PubMed  Google Scholar 

  • Hunter KF, Voaklander D, Hsu ZY, Moore KN (2013) Lower urinary tract symptoms and falls risk among older women receiving home support: a prospective cohort study. BMC Geriatr 13:46

    Article  PubMed  PubMed Central  Google Scholar 

  • Husch T, Neuerburg T, Reitz A (2016) Haferkamp A [The ice water test and bladder cooling reflex. Physiology, pathophysiology and clinical importance]. Urologe A 55:499–505

    Article  CAS  PubMed  Google Scholar 

  • Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 108:1132–1138

    Article  PubMed  Google Scholar 

  • Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306–1314

    Google Scholar 

  • Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S (2009a) Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol 56:14–20

    Article  PubMed  Google Scholar 

  • Irwin DE, Mungapen L, Milsom I, Kopp Z, Reeves P, Kelleher C (2009b) The economic impact of overactive bladder syndrome in six Western countries. BJU Int 103:202–209

    Article  PubMed  Google Scholar 

  • Jacob P, Rai BP, Todd AW (2012) Suprapubic catheter insertion using an ultrasound-guided technique and literature review. BJU Int 110:779–784

    Article  PubMed  Google Scholar 

  • Jeffery S, Fynes M, Lee F, Wang K, Williams L, Morley R (2007) Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int 100:1302–1306

    Article  CAS  PubMed  Google Scholar 

  • Johnson TM 2nd, Kincade JE, Bernard SL, Busby-Whitehead J, Hertz-Picciotto I, DeFriese GH (1998) The association of urinary incontinence with poor self-rated health. J Am Geriatr Soc 46:693–699

    Article  PubMed  Google Scholar 

  • Jorgensen L, Engstad T, Jacobsen BK (2005) Self-reported urinary incontinence in noninstitutionalized long-term stroke survivors: a population-based study. Arch Phys Med Rehabil 86:416–420

    Article  PubMed  Google Scholar 

  • Jura YH, Townsend MK, Curhan GC, Resnick NM, Grodstein F (2011) Caffeine intake, and the risk of stress, urgency and mixed urinary incontinence. J Urol 185:1775–1780

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Karsenty G, Baverstock R, Carlson K, Diaz DC, Cruz F, Dmochowski R, Fulford S, Giannantoni A, Heesakkers J, Kaufmann A, Peyrat L, Thavaseelan J, Dasgupta P (2014) Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure. Int J Clin Pract 68:731–742

    Google Scholar 

  • Kaviani A, Khavari R (2017) Disease-specific outcomes of botulinum toxin injections for neurogenic detrusor overactivity. Urol Clin North Am 44:463–474

    Article  PubMed  PubMed Central  Google Scholar 

  • Khullar V, Cambronero J, Angulo JC, Wooning M, Blauwet MB, Dorrepaal C, Martin NE (2013) Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial. BMC Urol 13:45

    Google Scholar 

  • Klotz T, Bruggenjurgen B, Burkart M, Resch A (2007) The economic costs of overactive bladder in Germany. Eur Urol 51:1654–1662

    Article  PubMed  Google Scholar 

  • Knüpfer SC, Schneider SA, Averhoff MM, Naumann CM, Deuschl G, Jünemann KP, Hamann MF (2016) Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson’s disease. BMC Urol 16:55

    Google Scholar 

  • Krhut J, Zachoval R, Smith PP, Rosier PF, Valanský L, Martan A, Zvara P (2014) Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn 33:507–510

    Google Scholar 

  • Ku JH, Ko DW, Cho JY, Oh SJ (2010) Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms. Urology 75:1467–1471

    Article  PubMed  Google Scholar 

  • Kuo HC, Liao CH, Chung SD (2010) Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome. Eur Urol 58:919–926

    Article  CAS  PubMed  Google Scholar 

  • Kuo HC (2003) Urodynamic study and potassium sensitivity test for women with frequency-urgency syndrome and interstitial cystitis. Urol Int 71:61–65

    Article  PubMed  Google Scholar 

  • Kurita N, Yamazaki S, Fukumori N, Otoshi K, Otani K, Sekiguchi M, Onishi Y, Takegami M, Ono R, Horie S, Konno S, Kikuchi S, Fukuhara S (2013) Overactive bladder symptom severity is associated with falls in community-dwelling adults: LOHAS study. BMJ Open:3

    Google Scholar 

  • Lasserre A, Pelat C, Guéroult V, Hanslik T, Chartier-Kastler E, Blanchon T, Ciofu C, Montefiore ED, Alvarez FP, Bloch J (2009) Urinary incontinence in French women: prevalence, risk factors, and impact on quality of life. Eur Urol 56:177–183

    Google Scholar 

  • Lee HE, Cho SY, Lee S, Kim M, Oh SJ (2013) Short-term effects of a systematized bladder training program for idiopathic overactive bladder: a prospective study. Int Neurourol J 17:11–17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee KS, Han DH, Lee YS, Choo MS, Yoo TK, Park HJ, Yoon H, Jeong H, Lee SJ, Kim H, Park WH (2010) Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8-week prospective study. J Korean Med Sci 25:117–122

    Google Scholar 

  • Lekka E, Lee LK (2006) Successful treatment with intradetrusor Botulinum-A toxin for urethral urinary leakage (catheter bypassing) in patients with end-staged multiple sclerosis and indwelling suprapubic catheters. Eur Urol 50:806–809

    Article  PubMed  Google Scholar 

  • Liberman JN, Hunt TL, Stewart WF, Wein A, Zhou Z, Herzog AR, Lipton RB, Diokno AC (2001) Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urol 57:1044–1050

    Google Scholar 

  • Lucioni A, Bales GT, Lotan TL, McGehee DS, Cook SP, Rapp DE (2008) Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int 101:366–370

    Article  CAS  PubMed  Google Scholar 

  • Malhotra B, Dickins M, Alvey C, Jumadilova Z, Li X, Duczynski G, Gandelman K (2011) Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects. Br J Clin Pharmacol 72:263–269

    Google Scholar 

  • Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E (2009) Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa. J Pharmacol Exp Ther 328:893–899

    Google Scholar 

  • Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E (2005) Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol 144:1089–1099

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mansfield KJ, Liu L, Moore KH, Vaux KJ, Millard RJ, Burcher E (2007) Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity. BJU Int 99:1433–1438

    Article  CAS  PubMed  Google Scholar 

  • Margalith I, Gillon G, Gordon D (2004) Urinary incontinence in women under 65: quality of life, stress related to incontinence and patterns of seeking health care. Qual Life Res 13:1381–1390

    Article  PubMed  Google Scholar 

  • Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A (2003) Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urol 62:259–264

    Article  PubMed  Google Scholar 

  • Mariappan P, Alhasso A, Ballantyne Z, Grant A, N’Dow J (2007) Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol 51:67–74

    Article  CAS  PubMed  Google Scholar 

  • McClurg D, Lowe-Strong A, Ashe R (2009) Pelvic floor training for lower urinary tract dysfunction in MS. Nurs Times 105:45–47

    PubMed  Google Scholar 

  • McDowell BJ, Engberg S, Sereika S, Donovan N, Jubeck ME, Weber E, Engberg R (1999) Effectiveness of behavioral therapy to treat incontinence in homebound older adults. J Am Geriatr Soc 47:309–318

    Google Scholar 

  • McGrother CW1, Donaldson MM, Hayward T, Matthews R, Dallosso HM, Hyde C (2006) Urinary storage symptoms and comorbidities: a prospective population cohort study in middle-aged and older women. Age Ageing 35:16–24

    Google Scholar 

  • Meel TD van, Wachter S De, Wyndaele JJ (2010) The effect of intravesical oxybutynin on the ice water test and on electrical perception thresholds in patients with neurogenic detrusor overactivity. Neurourol Urodyn 29:391–394

    PubMed  Google Scholar 

  • Milsom I (2000) The prevalence of urinary incontinence. Acta Obstet Gynecol Scand 79:1056–1059

    CAS  PubMed  Google Scholar 

  • Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87:760–766

    Article  CAS  PubMed  Google Scholar 

  • Minardi D, Muzzonigro G (2012) Sacral neuromodulation in patients with multiple sclerosis. World J Urol 30:123–128

    Article  PubMed  Google Scholar 

  • Moehrer B, Hextall A, Jackson S (2003) Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev:CD001405

    Google Scholar 

  • Moon SJ, Kim YT, Lee TY, Moon H, Kim MJ, Kim SA, Choi BY (2011) The influence of an overactive bladder on falling: a study of females aged 40 and older in the community. Int Neurourol J 15:41–47

    Google Scholar 

  • Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J (2006) Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev:CD003781

    Google Scholar 

  • Nelson HD, Walker M, Zakher B, Mitchell J (2012) Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations. Ann Intern Med 157:104–113

    Article  PubMed  Google Scholar 

  • Nelson RL, Furner SE (2005) Risk factors for the development of fecal and urinary incontinence in Wisconsin nursing home residents. Maturitas 52:26–31

    Article  PubMed  Google Scholar 

  • Nitti VW (1993) Ice-water test in urodynamic assessment. Lancet 342:1066–1067

    Article  CAS  PubMed  Google Scholar 

  • Nitti VW, Chapple CR, Walters C, Blauwet MB, Herschorn S, Milsom I, Auerbach S, Radziszewski P (2014) Safety and tolerability of the beta3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial. Int J Clin Pract 68:972–985

    Google Scholar 

  • Nitti VW, Rovner ES, Bavendam T (2010) Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int 105:1268–1275

    Article  CAS  PubMed  Google Scholar 

  • Obara K, Chino D, Tanaka Y (2017) Distigmine bromide produces sustained potentiation of guinea-pig urinary bladder motility by inhibiting cholinesterase activity. Biol Pharm Bull 40:807–814

    Article  CAS  PubMed  Google Scholar 

  • Onukwugha E, Zuckerman IH, McNally D, Coyne KS, Vats V, Mullins CD (2009) The total economic burden of overactive bladder in the United States: a disease-specific approach. Am J Manag Care 15:90–97

    Google Scholar 

  • Ouslander JG, Kane RL, Abrass IB (1982) Urinary incontinence in elderly nursing home patients. JAMA 248:1194–1198

    Article  CAS  PubMed  Google Scholar 

  • Palmero Marti JL, Bonillo Garcia MA, Pacheco Bru JJ, Alapont Alacreu JM, Garcia Reboll L (2003) Jimenez Cruz JF [Necrosis of the skin of the penis as a complication of the use of a urine collector]. Actas Urol Esp 27:155–158

    Article  CAS  PubMed  Google Scholar 

  • Panayi DC, Khullar V, Digesu GA, Spiteri M, Hendricken C, Fernando R (2011) Rectal distension: the effect on bladder function. Neurourol Urodyn 30:344–347

    Article  CAS  PubMed  Google Scholar 

  • Patel MD, McKevitt C, Lawrence E, Rudd AG, Wolfe CD (2007) Clinical determinants of long-term quality of life after stroke. Age Ageing 36:316–322

    Article  CAS  PubMed  Google Scholar 

  • Phé V, Léon P, Granger B, Denys P, Bitker MO, Mozer P, Chartier-Kastler E (2017) Stress urinary incontinence in female neurological patients: long-term functional outcomes after artificial urinary sphincter (AMS 800(TM)) implantation. Neurourol Urodyn 36:764–769

    Google Scholar 

  • Pietzko A, Dimpfel W, Schwantes U, Topfmeier P (1994) Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol 47:337–343

    Article  CAS  PubMed  Google Scholar 

  • Pils K, Neumann F, Meisner W, Schano W, Vavrovsky G, Van der Cammen TJ (2003) Predictors of falls in elderly people during rehabilitation after hip fracture–who is at risk of a second one? Z Gerontol Geriatr 36:16–22

    Article  CAS  PubMed  Google Scholar 

  • Resnick NM, Yalla SV, Laurino E (1989) The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med 320:1–7

    Article  CAS  PubMed  Google Scholar 

  • Richardson JP, Hricz L (1995) Risk factors for the development of bacteremia in nursing home patients. Arch Fam Med 4:785–789

    Article  CAS  PubMed  Google Scholar 

  • Ringert RH (1996) Gross AJ Bladder catheter or suprapubic fistula? Indications and contraindications. Langenbecks Arch Chir Suppl Kongressbd 113:713–717

    Google Scholar 

  • Rodrigues P, Meller A, Campagnari JC, Alcantara D, D’Imperio M (2004) International Prostate Symptom Score–IPSS-AUA as discriminat scale in 400 male patients with lower urinary tract symptoms (LUTS). Int Braz J Urol 30:135–141

    Article  PubMed  Google Scholar 

  • Sakakibara R, Tateno F, Nagao T, Yamamoto T, Uchiyama T, Yamanishi T, Yano M, Kishi M, Tsuyusaki Y, Aiba Y (2014) Bladder function of patients with Parkinson’s disease. Int J Urol 21:638–646

    Google Scholar 

  • Sanchez Raya J, Romero Culleres G, Gonzalez Viejo MA, Ramirez Garceran L, Garcia Fernandez L (2010) Conejero Sugranes [Quality of life evaluation in spinal cord injured patients comparing different bladder management techniques]. J. Actas Urol Esp 34:537–542

    Article  CAS  Google Scholar 

  • Sand PK, Dmochowski RR, Reddy J, van der Meulen EA (2013) Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol 190:958–964

    Article  CAS  PubMed  Google Scholar 

  • Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261–274

    Google Scholar 

  • Schmid DM, Sauermann P, Wener M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176:177–185

    Google Scholar 

  • Schulte-Baukloh H, Weiss C, Stolze T, Sturzebecher B, Knispel HH (2005) Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urol 66:82–87

    Article  PubMed  Google Scholar 

  • Schurch B, Hauri D, Largo M, Kreienbuhl B, Meyer E, Rossier AB (1990) Effects of Botulinum A Toxin on the periurethral striated sphincter of the neurogenic bladder. preliminary study. J Urol 96:375–380 (Paris)

    Google Scholar 

  • Schwantes U, Grosse J, Wiedemann A (2015) Refractory overactive bladder: a common problem? Int Urogynecol J 26:1407–1414

    Article  PubMed  PubMed Central  Google Scholar 

  • Sgadari A, Topinkova E, Bjornson J, Bernabei R (1997) Urinary incontinence in nursing home residents: a cross-national comparison. Age Ageing 26(Suppl 2):49–54

    Article  PubMed  Google Scholar 

  • Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennet J, Zylstra S, Kan F, Thiery E (2016) Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. Urol 94:57–63

    Google Scholar 

  • Smith AL, Wein AJ (2011) Urinary incontinence: pharmacotherapy options. Ann Med 43:461–476

    Article  CAS  PubMed  Google Scholar 

  • Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB (2004) Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urol 64:871–875

    Article  PubMed  Google Scholar 

  • Soroka D, Drutz HP, Glazener CM, Hay-Smith EJ, Ross S (2002) Perineal pad test in evaluating outcome of treatments for female incontinence: a systematic review. Int Urogynecol J Pelvic Floor Dysfunct 13:165–175

    Article  CAS  PubMed  Google Scholar 

  • Stewart K, McGhan WF, Offerdahl T, Corey R (2002) Overactive bladder patients and role of the pharmacist. J Am Pharm Assoc (Wash) 42:469–476 (quiz 77–78)

    Google Scholar 

  • Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336

    Google Scholar 

  • Stoffel JT (2016) Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies. Transl Androl Urol 5:127–135

    Article  PubMed  PubMed Central  Google Scholar 

  • Stothers L (2004) Reliability, validity, and gender differences in the quality of life index of the SEAPI-QMM incontinence classification system. Neurourol Urodyn 23:223–228

    Article  PubMed  Google Scholar 

  • Suhr R, Lahmann NA (2017) Urinary incontinence in home care: a representative multicenter study on prevalence, severity, impact on quality of life, and risk factors. Aging Clin Exp Res

    Google Scholar 

  • Svihra J, Krhut J, Zachoval R, Svihrova V, Luptak J (2017) Impact of clean intermittent catheterization on quality adjusted life years (QALYs) in spinal cord injury patients with neurogenic urinary incontinence. Neurourol Urodyn 37(1):250–256

    Google Scholar 

  • Takazawa K, Arisawa K (2005) Relationship between the type of urinary incontinence and falls among frail elderly women in Japan. J Med Invest 52:165–171

    Article  PubMed  Google Scholar 

  • Temml C, Heidler S, Ponholzer A, Madersbacher S (2005) Prevalence of the overactive bladder syndrome by applying the International Continence Society definition. Eur Urol 48:622–627

    Article  PubMed  Google Scholar 

  • Thom DH, Haan MN, Van Den Eeden SK (1997) Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing 26:367–374

    Article  CAS  PubMed  Google Scholar 

  • Thor KB, de Groat WC (2010) Neural control of the female urethral and anal rhabdosphincters and pelvic floor muscles. Am J Physiol Regul Integr Comp Physiol 299:R416–R438

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Turhan N, Atalay A, Atabek HK (2006) Significance of poststroke urinary incontinence as a negative predictor of functional recovery on the basis of aging. J Am Geriatr Soc 54:1022–1023

    Article  PubMed  Google Scholar 

  • Vaart CH van der, Leeuw JR de, Roovers JP (2000) Heintz AP [The influence of urinary incontinence on quality of life of community-dwelling, 45–70 year old Dutch women]. Ned Tijdschr Geneeskd 144:894–897

    PubMed  Google Scholar 

  • Vasquez N, Knight SL, Susser J, Gall A, Ellaway PH, Craggs MD (2015) Pelvic floor muscle training in spinal cord injury and its impact on neurogenic detrusor over-activity and incontinence. Spinal Cord 53:887–889

    Article  CAS  PubMed  Google Scholar 

  • Vetter NJ, Jones DA, Victor CR (1981) Urinary incontinence in the elderly at home. Lancet 2:1275–1277

    Article  CAS  PubMed  Google Scholar 

  • Wagner TH, Hu TW, Bentkover J et al (2002) Health-related consequences of overactive bladder. Am J Manag Care 8:S598–S607

    PubMed  Google Scholar 

  • Wagner TH, Hu TW (1998) Economic costs of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 9:127–128

    Article  CAS  PubMed  Google Scholar 

  • Wein AJ (2005) Impact of urinary incontinence after stroke: results from a prospective population-based stroke register. J Urol 173:2057

    PubMed  Google Scholar 

  • Wein AJ, Rackley RR (2006) Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 175:S5–S10

    Article  PubMed  Google Scholar 

  • Weiss JP, Herschorn S, Albei CD, van der Meulen EA (2013) Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol 190:965–972

    Article  CAS  PubMed  Google Scholar 

  • Welz-Barth A, A W, D W, I F (2001) Tabu-Erkrankung Harninkontinenz - auch in der urologischen Praxis?

    Google Scholar 

  • Welz-Barth A, Fusgen I, Melchior HJ (2000) 1999 rerun of the 1996 German Urinary Incontinence Survey: will doctors ever ask? World J Urol 18:436–438

    Article  CAS  PubMed  Google Scholar 

  • White WM, Pickens RB, Doggweiler R, Klein FA (2008) Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population. J Urol 180:2522–2526

    Article  CAS  PubMed  Google Scholar 

  • Wiedemann A, Kaeder M, Greulich W, Lax H, Priebel J, Kirschner-Hermanns R, Füsgen I (2013) Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases. World J Urol 31:229–233

    Google Scholar 

  • Wilde MH, Getliffe K, Brasch J, McMahon J, Anson E, Tu X (2010) A new urinary catheter-related quality of life instrument for adults. Neurourol Urodyn 29:1282–1285

    Article  PubMed  Google Scholar 

  • Wilkins K (1999) Medications and fall-related fractures in the elderly. Health Rep 11:45–53

    CAS  PubMed  Google Scholar 

  • Winge K, Skau AM, Stimpel H, Nielsen KK, Werdelin L (2006) Prevalence of bladder dysfunction in Parkinsons disease. Neurourol Urodyn 25:116–122

    Article  PubMed  Google Scholar 

  • Wüllner U, Schmitz-Hübsch T, Antony G, Fimmers R, Spottke A, Oertel WH, Deuschl G, Klockgether T, Eggert K (2007) Autonomic dysfunction in 3414 Parkinson’s disease patients enrolled in the German Network on Parkinson’s disease (KNP e. V.): the effect of ageing. Eur J Neurol 14:1405–1408

    Google Scholar 

  • Yarnell JW, St Leger AS (1979) The prevalence, severity and factors associated with urinary incontinence in a random sample of the elderly. Age Ageing 8:81–85

    Article  CAS  PubMed  Google Scholar 

  • Yoshida M, Inadome A, Maeda Y et al (2006) Non-neuronal cholinergic system in human bladder urothelium. Urol 67:425–430

    Article  PubMed  Google Scholar 

  • Zachariou A, Filiponi M, Baltogiannis D, Giannakis J, Dimitriadis F, Tsounapi P, Takenaka A, Sofikitis N (2017) Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron. Can J Urol 24:9107–9113

    Google Scholar 

  • Zia A, Kamaruzzaman SB, Tan MP (2015) Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk. Postgrad Med 127:330–337

    Article  PubMed  Google Scholar 

  • Zia A, Kamaruzzaman S, Myint PK, Tan MP (2016) Anticholinergic burden is associated with recurrent and injurious falls in older individuals. Maturitas 84:32–37

    Article  PubMed  Google Scholar 

  • Zorn BH, Montgomery H, Pieper K, Gray M, Steers WD (1999) Urinary incontinence and depression. J Urol 162:82–84

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik, Ev. Krankenhaus Witten gGmbH, Witten, Deutschland

    Andreas Wiedemann

  2. Neuro-Urologie, Urologische Klinik - Universitätsklinikum Bonn, Rheinische Friedrich-Wilhelms Universität und Neurologisches Rehabilitationszentrum Godeshöhe e.V.Bonn, Bonn, Deutschland

    Ruth Kirschner-Hermanns

  3. Klinik für Geriatrie mit Neurologie, Johanniter Krankenhaus Bonn, Bonn, Deutschland

    Andreas H. Jacobs

Authors
  1. Andreas Wiedemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruth Kirschner-Hermanns
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andreas H. Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Wiedemann .

Editor information

Editors and Affiliations

  1. Klinik für Neurologie, UKSH, Campus Kiel, Kiel, Germany

    Walter Maetzler

  2. Lehrstuhl für Geriatrie, Universitätsklinikum Essen, Geriatriezentrum Haus Berge, Contilia Group, Essen, Germany

    Richard Dodel

  3. Klinik für Geriatrie mit Neurologie, Johanniter Krankenhaus Bonn, Bonn, Germany

    Andreas H. Jacobs

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wiedemann, A., Kirschner-Hermanns, R., Jacobs, A.H. (2019). Harninkontinenz. In: Maetzler, W., Dodel, R., Jacobs, A. (eds) Neurogeriatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57358-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57358-7_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57357-0

  • Online ISBN: 978-3-662-57358-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation